Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CLELAND

Showing results (341-350 of 663) with videos related to

Pageof 67
Sort By:
Current Treatment Options in Cardiovascular Medicine|December 6, 2011
Use of carotid intima-media thickness regression to guide therapy and management of cardiac risksP Costanzo, J G Cleland, S L Atkin, et al.
American Heart Journal|July 1, 1986
The effects of captopril on serum digoxin and urinary urea and digoxin clearances in patients with congestive heart failureJ G Cleland, H J Dargie, A Pettigrew, et al.
Lancet (London, England)|September 15, 1999
Survival trends, coronary event rates, and the MONICA project. Monitoring trends and determinants in cardiovascular diseaseF Alamgir, J L Caplin, J G Cleland, et al.
Journal of the American College of Cardiology|March 1, 1991
Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failureJ G Cleland, E Henderson, J McLenachan, et al.
The Medical Journal of Australia|May 27, 2003
Pulmonary arterial hypertension: a new era in managementAnne M Keogh, Keith D McNeil, Trevor Williams, et al.
Blood|March 21, 1998
Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytesM Pouliot, M J James, S R McColl, et al.
Neurology|November 26, 2003
Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelicH Houlden, S Lincoln, M Farrer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitorsP S Penglis, L G Cleland, M Demasi, et al.
The American Journal of Cardiology|March 11, 2008
Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathyRobert G Metcalf, Prashanthan Sanders, Michael J James, et al.
European Journal of Heart Failure|August 21, 2001
Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHFS Thackray, A Coletta, P Jones, et al.
Pageof 67

Showing results (341-350 of 663) with videos related to

Sort By:
Pageof 67
Current Treatment Options in Cardiovascular Medicine|December 6, 2011
Use of carotid intima-media thickness regression to guide therapy and management of cardiac risksP Costanzo, J G Cleland, S L Atkin, et al.
American Heart Journal|July 1, 1986
The effects of captopril on serum digoxin and urinary urea and digoxin clearances in patients with congestive heart failureJ G Cleland, H J Dargie, A Pettigrew, et al.
Lancet (London, England)|September 15, 1999
Survival trends, coronary event rates, and the MONICA project. Monitoring trends and determinants in cardiovascular diseaseF Alamgir, J L Caplin, J G Cleland, et al.
Journal of the American College of Cardiology|March 1, 1991
Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failureJ G Cleland, E Henderson, J McLenachan, et al.
The Medical Journal of Australia|May 27, 2003
Pulmonary arterial hypertension: a new era in managementAnne M Keogh, Keith D McNeil, Trevor Williams, et al.
Blood|March 21, 1998
Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytesM Pouliot, M J James, S R McColl, et al.
Neurology|November 26, 2003
Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelicH Houlden, S Lincoln, M Farrer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitorsP S Penglis, L G Cleland, M Demasi, et al.
The American Journal of Cardiology|March 11, 2008
Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathyRobert G Metcalf, Prashanthan Sanders, Michael J James, et al.
European Journal of Heart Failure|August 21, 2001
Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHFS Thackray, A Coletta, P Jones, et al.
Pageof 67